Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HSBC Holdings plc (HSBC) vs Moderna, Inc. (MRNA) Price & Performance

HSBC Holdings plcTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

HSBC Holdings plc vs Moderna, Inc. — how do they compare? HSBC Holdings plc trades at $101.09 (market cap $335.21B), while Moderna, Inc. trades at $59.38 (market cap $23.60B). The key difference: HSBC Holdings plc is far larger — about 14.2× Moderna, Inc.'s market cap, and HSBC Holdings plc pays a 3.79% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

HSBCMRNA
Market Cap
$335.21B$23.60B
Sector
TechnologyHealth
52-Week High
$100.61$81.80
52-Week Low
$61.30$22.36
Dividend Yield
3.79%
Enterprise Value
$19.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HSBC Holdings plc

HSBC trades at $99.01, down 1.59% today but near its 52-week high of $99.47. The stock shows strong technical momentum with bullish moving averages, though oscillators suggest potential overbought conditions. Fundamentally, the bank maintains robust profitability with 30.81% net income margin and 10.89% ROE, supported by recent earnings beats and a $0.50 dividend declaration. Recent news highlights strategic moves including AI partnerships and business portfolio optimization.

HSBC presents a mixed outlook with solid fundamentals and strategic initiatives balanced against valuation concerns and regional risks. The bank's focus on AI integration and market exits could drive efficiency, but regulatory challenges and economic uncertainty pose headwinds. Analyst consensus leans cautious with 38% buy ratings, suggesting selective opportunity for long-term investors despite near-term overbought signals.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA